Table 2.

Morphine consumption and NRS, ambulation, sedation, and N/V scores

	Group T (n=20)	Group P (n=20)	Mean difference	95% CI	P-value
Morphine consumption in 24 hours (mg)	15.40 (12.65)	33.60 (19.06)	−18.20	−28.55 to −7.85	0.001
Morphine consumption in 48 hours (mg)	24.90 (20.11)	57.80 (28.70)	−32.90	−48.76 to −17.04	<0.001
NRS score at rest	2.73 (1.95)	4.64 (1.60)	−1.91	−3.05 to −0.77	0.002
NRS score during movement	4.39 (2.37)	6.42 (1.40)	−2.02	−3.27 to −0.78	0.002
Ambulation score	0.60 (0.18)	0.44 (0.23)	0.15	0.02 to 0.29	0.026
Sedation score	0.27 (0.29)	0.18 (0.23)	0.09	−0.08 to 0.25	0.299
N/V score	0.59 (0.44)	0.31 (0.38)	0.29	0.02 to 0.55	0.033

Notes: Group T patients received a transdermal fentanyl patch; group P patients received placebo. Data presented as means (standard deviation).

Abbreviations: CI, confidence interval; NRS, numeric rating scale; N/V, nausea/vomiting.